These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 34724198)
1. Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing. Lu E; Hatchell KE; Nielsen SM; Esplin ED; Ouyang K; Nykamp K; Zavoshi S; Li S; Zhang L; Wilde BR; Christofk HR; Boutros PC; Shuch B Cancer; 2022 Feb; 128(4):675-684. PubMed ID: 34724198 [TBL] [Abstract][Full Text] [Related]
2. Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer. Shuch B; Li S; Risch H; Bindra RS; McGillivray PD; Gerstein M Cancer; 2020 Aug; 126(16):3657-3666. PubMed ID: 32413184 [TBL] [Abstract][Full Text] [Related]
3. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Sanz-Ortega J; Vocke C; Stratton P; Linehan WM; Merino MJ Am J Surg Pathol; 2013 Jan; 37(1):74-80. PubMed ID: 23211287 [TBL] [Abstract][Full Text] [Related]
4. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals. Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373 [TBL] [Abstract][Full Text] [Related]
5. Case report: response to immunotherapy and association with the fh gene in hereditary leiomyomatosis and renal cell cancer-associated renal cell cancer. Gao F; Gu D; Zhang H; Shi C; Du F; Zheng B; Wu H; Zhao Y BMC Med Genomics; 2024 Aug; 17(1):215. PubMed ID: 39160519 [TBL] [Abstract][Full Text] [Related]
6. Novel morphological and genetic features of fumarate hydratase deficient renal cell carcinoma in HLRCC syndrome patients with a tailored therapeutic approach. Wyvekens N; Valtcheva N; Mischo A; Helmchen B; Hermanns T; Choschzick M; Hötker AM; Rauch A; Mühleisen B; Akhoundova D; Weber A; Moch H; Rupp NJ Genes Chromosomes Cancer; 2020 Nov; 59(11):611-619. PubMed ID: 32537760 [TBL] [Abstract][Full Text] [Related]
7. Fumarate Hydratase Variants and Their Association With Paraganglioma/Pheochromocytoma. Zavoshi S; Lu E; Boutros PC; Zhang L; Harari A; Hatchell KE; Nielsen SM; Esplin ED; Ouyang K; Nykamp K; Wilde B; Christofk H; Shuch B Urology; 2023 Jun; 176():106-114. PubMed ID: 36773955 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and molecular features of hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinomas. Furuya M; Iribe Y; Nagashima Y; Kambe N; Ohe C; Kinoshita H; Sato C; Kishida T; Okubo Y; Numakura K; Nanjo H; Nakaigawa N; Makiyama K; Hasumi H; Iwashita H; Ohta J; Kitamura H; Nakajima T; Yoshida T; Nakagawa M; Tanaka R; Yao M J Clin Pathol; 2020 Dec; 73(12):819-825. PubMed ID: 32376712 [TBL] [Abstract][Full Text] [Related]
9. Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer. Stewart L; Glenn GM; Stratton P; Goldstein AM; Merino MJ; Tucker MA; Linehan WM; Toro JR Arch Dermatol; 2008 Dec; 144(12):1584-92. PubMed ID: 19075141 [TBL] [Abstract][Full Text] [Related]
10. Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome: A 5-Year Single Institutional Experience. Rabban JT; Chan E; Mak J; Zaloudek C; Garg K Am J Surg Pathol; 2019 May; 43(5):639-655. PubMed ID: 30741757 [TBL] [Abstract][Full Text] [Related]
11. Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma. Zhang L; Walsh MF; Jairam S; Mandelker D; Zhong Y; Kemel Y; Chen YB; Musheyev D; Zehir A; Jayakumaran G; Brzostowski E; Birsoy O; Yang C; Li Y; Somar J; DeLair D; Pradhan N; Berger MF; Cadoo K; Carlo MI; Robson ME; Stadler ZK; Iacobuzio-Donahue CA; Joseph V; Offit K Hum Mutat; 2020 Jan; 41(1):103-109. PubMed ID: 31444830 [TBL] [Abstract][Full Text] [Related]
13. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma. Kopp RP; Stratton KL; Glogowski E; Schrader KA; Rau-Murthy R; Russo P; Coleman JA; Offit K Cancer; 2017 Jul; 123(13):2452-2458. PubMed ID: 28171700 [TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature. Hol JA; Jongmans MCJ; Littooij AS; de Krijger RR; Kuiper RP; van Harssel JJT; Mensenkamp A; Simons M; Tytgat GAM; van den Heuvel-Eibrink MM; van Grotel M Fam Cancer; 2020 Jan; 19(1):55-63. PubMed ID: 31792767 [TBL] [Abstract][Full Text] [Related]
15. Fumarate hydratase c.914T > C (p.Phe305Ser) is a pathogenic variant associated with hereditary leiomyomatosis and renal cell cancer syndrome. Breen KE; Carlo MI; Kemel Y; Maio A; Chen YB; Zhang L; Ceyhan-Birsoy O; Mandelker D Mol Genet Genomic Med; 2020 Aug; 8(8):e1293. PubMed ID: 32463173 [TBL] [Abstract][Full Text] [Related]
16. In deep bioinformatic characterization of a novel fumarate hydratase variant FH c.199T > G; (p.Tyr67Asp) in hereditary leiomyomatosis and renal cell carcinoma. Chami A; de Souza Zózimo TR; Alves TM; Matosinho CGR; Santos C; Simões MM; Cabral WLR; de Paula Ricardo BF; da Silva Filho AL; Carvalho MRS; da Conceição Braga L Fam Cancer; 2023 Oct; 22(4):481-486. PubMed ID: 37316640 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of somatic and germline mutations of Fumarate hydratase in uterine leiomyomas from young patients. Liu C; Dillon J; Beavis AL; Liu Y; Lombardo K; Fader AN; Hung CF; Wu TC; Vang R; Garcia JE; Xing D Histopathology; 2020 Feb; 76(3):354-365. PubMed ID: 31564060 [TBL] [Abstract][Full Text] [Related]
18. A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC). Bhola PT; Gilpin C; Smith A; Graham GE Fam Cancer; 2018 Oct; 17(4):615-620. PubMed ID: 29423582 [TBL] [Abstract][Full Text] [Related]
19. Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation. da Cunha IW; da Costa WH; Morini MA; Bezerra SM; Carraro DM; Torrezan GT; Formiga MNC; Guimaraes GC; Zequi SC; Soares FA Virchows Arch; 2018 Dec; 473(6):775-779. PubMed ID: 30171332 [TBL] [Abstract][Full Text] [Related]
20. Fumarate hydratase as a therapeutic target in renal cancer. Kancherla P; Daneshvar M; Sager RA; Mollapour M; Bratslavsky G Expert Opin Ther Targets; 2020 Sep; 24(9):923-936. PubMed ID: 32744123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]